Mount Sinai Medical School

molecule-computer.jpgIPNews® – Humanetics announced that after years of research and development with Mount Sinai Medical School, it has been granted a patent for its Alzheimer’s disease treatment. 

The newly patented compound NIC5-15 includes methodology for preventing the formation of beta-amyloid plaques, which is widely believed to be the leading cause of Alzheimer’s disease.  The Minnesota